NEW YORK (360Dx) – Thermo Fisher Scientific said this week that it has qualified global reference laboratories Laboratory Corporation of America and Cancer Genetics to join its Next-Generation Sequencing Companion Dx Center of Excellence Program (COEP).

To qualify for the COEP, all laboratory members must demonstrate high-level expertise in oncology testing, maintain a global footprint, and meet the criteria necessary to administer clinical trials for the development and commercialization of companion diagnostic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.